Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bellavie Woman
- Development stage
- Unknown
- Lead developer
- BellaVie
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Bellavie Woman is a synbioceutical dietary supplement developed by the Belgian company BellaVie and marketed by Rameda. It is formulated specifically to support women's vaginal, urinary, and digestive health. The product contains a synergistic blend of seven probiotic strains (including *Lactobacillus crispatus*, *Lactobacillus rhamnosus*, and *Bacillus coagulans*), prebiotic inulin fiber, and cranberry extract rich in proanthocyanidins. This combination helps maintain a balanced gut and vaginal microbiota, prevents the overgrowth of pathogens associated with bacterial vaginosis, and reduces the adherence of bacteria in the urinary tract to lower the risk of urinary tract infections.
- Brand names
- BellaVie Woman
- Other names
- BellaVie Synbioceutical Woman
Beyond the preview
Go deeper on Bellavie Woman.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bellavie Woman.